Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trial.

arbaclofen baclofen extended-release multiple sclerosis spasticity

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2022
Historique:
received: 04 05 2022
revised: 27 08 2022
accepted: 21 11 2022
entrez: 15 12 2022
pubmed: 16 12 2022
medline: 16 12 2022
Statut: epublish

Résumé

Baclofen, a racemic GABA-B (GABA

Identifiants

pubmed: 36519155
doi: 10.1093/braincomms/fcac300
pii: fcac300
pmc: PMC9732858
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcac300

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Cochrane Database Syst Rev. 2003;(4):CD001332
pubmed: 14583932
Compr Psychiatry. 2009 May-Jun;50(3):257-62
pubmed: 19374971
Eur Neurol. 2014;71 Suppl 1:1-3
pubmed: 24457845
Phys Med Rehabil Clin N Am. 2013 Nov;24(4):593-604
pubmed: 24314678
Phys Ther. 1987 Feb;67(2):206-7
pubmed: 3809245
Can J Neurol Sci. 1979 Aug;6(3):351-4
pubmed: 385132
Drug Saf. 2004;27(11):799-818
pubmed: 15350152
J Rehabil Med. 2017 Mar 6;49(3):193-203
pubmed: 28233010
Curr Neurol Neurosci Rep. 2019 Aug 30;19(10):79
pubmed: 31471769
Expert Rev Neurother. 2013 Dec;13(12 Suppl):55-9
pubmed: 24289845
Neurology. 1978 Nov;28(11):1094-8
pubmed: 362234
J Neural Transm. 1984;60(1):63-7
pubmed: 6090584
Arch Neurol. 1977 Jul;34(7):422-8
pubmed: 327987
Practitioner. 1964 Apr;192:540-2
pubmed: 14143329
BMC Psychiatry. 2011 May 14;11:83
pubmed: 21569566
Eur Neurol. 2006;56(2):78-105
pubmed: 16966832
Pharmacology. 1983;27(2):85-94
pubmed: 6611651
Am J Manag Care. 2013 Feb;19(2 Suppl):S15-20
pubmed: 23544716
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Neurology. 1987 Nov;37(11):1725-8
pubmed: 3313099
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
J Neurochem. 1986 Sep;47(3):898-903
pubmed: 3016189
Nature. 1980 Jan 3;283(5742):92-4
pubmed: 6243177
Mult Scler. 2004 Oct;10(5):589-95
pubmed: 15471378
Patient. 2016 Dec;9(6):537-546
pubmed: 27154536
Annu Rev Pharmacol Toxicol. 1993;33:109-47
pubmed: 8388192
J Pharm Pharmacol. 1980 Mar;32(3):230-1
pubmed: 6103949
Urology. 2008 Apr;71(4):646-56
pubmed: 18313122
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009974
pubmed: 23450612
Eur J Pharmacol. 1978 Nov 1;52(1):133-6
pubmed: 214308
J Spinal Cord Med. 2005;28(2):167-99
pubmed: 15889701

Auteurs

Darin T Okuda (DT)

Neurology, The University of Texas Southwestern Medical Center, Dallas, TX 75390-8806, USA.

Daniel Kantor (D)

Neurology, Florida Atlantic University, Boca Raton, FL 33431, USA.
Clinical Immunology, Nova Southeastern University, Fort Lauderdale, FL 33314, USA.

Mark Jaros (M)

Summit Analytical, Denver, CO 80238, USA.

Tina deVries (T)

Research and Development, RVL Pharmaceuticals, Inc., Bridgewater, NJ 08807, USA.

Samuel Hunter (S)

Advanced Neurosciences Institute, Franklin, TN 37064, USA.

Classifications MeSH